BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES--02 Trial Advances and JPM Week Approaches

As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing what could become the first disease-modifying ...
EDN

Cadence to Acquire Simplex for $300M

In a day of consolidation for the EDA industry, Cadence Design Systems Inc. today announced it has signed a definitive merger agreement to acquire Simplex Solutions Inc. for $300 million in stock.
PharmiWeb

BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES‑02 Trial Advances and JPM Week Approaches

ROOTSTOWN, Ohio--(BUSINESS WIRE)--#Biotech--As BioMendics prepares to share its progress during the 2026 J.P. Morgan Healthcare Conference and Biotech Showcase, the Ohio-based biotech is advancing ...